Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This is my opinion posted on this board some time ago.
Absolutely. Without question.
After seeing the following:
I like the looks of this.
News article:
http://www.cbc.ca/news/canada/british-columbia/impaired-driving-marijuana-challenges-1.3431129
Check out the comment on Bill Blair and being put in charge of legalization in Canada.
And the older link:
http://www.cbc.ca/news/canada/british-columbia/cannabix-technologies-testing-marijuana-breathalyzer-prototype-1.3283771
When Beta is released for trial testing, the device will be presented publicly to the world for viewing and there, little to no chance, that this will stay in the teens. Once there is a viable, accurate working product which is patented and the only device of it's kind in the world, with the demand of every police station and many employers, it will sky rocket.
I would also disagree that people will just dump That is mere speculation. Most on this board are holding because they realize the potential value is in the TEEN DOLLAR range, not in the 1-2 dollar range.
You can search back through the board. I have posted many times on Hound Labs, specifically commenting on how I think they will use a different (tag molecule) methodology to detect THC in breath.
It is entirely speculative, as they have not gone public and nobody knows anything aside from their proposed timeline of having a working device in the next year or two.
My guess is that that they are no further ahead then we are, at this point in time as we also have a working device, that requires fine-tuning and trial testing.
Should be interesting how it plays out.
I agree with Nayam that there is no competition right now, as nobody has a device.
There is room in the market for two devices. However, the most accurate will win. With that said, we have the most accurate Mass Spectrometeric detection system for THC in the world at this time, by a country mile.
Nice post Shell3. I like your phrase "March to Mars with BLOZF".
Has anyone on this board thought about writing a news article, such as a personal commentary, and circulating it to marijuana and medical technology websites? Essentially doing the PR job for Cannabix? From a neutral standpoint, stressing positive points such as the recent licensing agreement exercise. I imagine a well written article, circulated to the right news station could be worthwhile.
Like any reasonable investor, if the company is not generating revenue, one can assume that there will not be a significant rise in SP. I would say that the rules in medical tech. start-ups like this are slightly different. These guys either build a device and make a ridiculous amount of money, because the science is so complex that there will be no other competitors, and demand for the device will be incredibly high. Or, they don't, and it is worthless.
My personal opinion: Prior to Yost, things were neither guaranteed, nor promising. After Yost, prior to the acquisition, a step in the right direction, but again, until they acquire the rights, we can't be sure testing of their combined Alpha-FAIMS device is proceeding well (i.e. left in the dark for 6 months). Now, post-acquisition, we know that they are working on something that has a high likelihood of working, otherwise Cannabix would not acquire the rights and Yost would not let Cannabix use their renonwned technology.
In a nut shell, you are right. However, there is less likely to be a decline, more likely a steady rise given the Breathtec funding to work on the same technology, the Beta that is likely to be released soon, and the surety provided by the acquisition of the rights.
Just my opinion.
I think people are starting to realize that these cheap shares are not going to last, which is great for those who have got in thus far at the current prices.
I would recommend that investors examine the documentation provided by the company on the CSE to get a good idea about the financials of the company, that way when they come here and observe the conversation, they do not panic under the assumption that this company is well funded, after having gone a major re-structuring with respect to product development and partnership. They should (but some haven't), realize how positive a private placement is following the acquisition of rights to a world-class technology (which in this industry is indicative of successful product development in the early stages - i.e. Beta).
What will be brilliant, is when these guys secure their private placement and release Beta at Pittcon. The last time we will see SP in this range.
Things are looking up ! BLOZF!
It is common when a stock is set to rise in SP, for those who want to pick up extra shares, to talk negatively to try and scare people so that they can pick up more. Those on this board should try and be aware of negative attitude in posts and pay attention to those that provide neutral positions and debate with fact.
That was in June of 2015. Not only is that post entirely outdated in terms of date, the fact remains that they were funded to complete their Alpha device. That statement pertained to Alpha, when they thought they were perhaps a month or two away from Beta. When they didn't come up with the accuracy needed, they sought a new scientific internal technology. That's where Yost group came in. They had to provide a grant to Yost and fund them. They need more capital now, because they likely need to fund a different beta and a clinical trial.
Do you acknoledge that there is a new (Yost) group in the picture, since the time of the outdated article you site?
If so:
Question, do you have any experience in medical technology development? If not, I can understand why you might not see how the development of a new product might incur a different set of costs then previously predicted. I will gladly explain how that might be the case... just let me know.
This company has not advised that they were full funded to the *end of product development*. You did not read the recent MD%A did you? Did you read the yearly financial reports done by the actuaries?
It has been publicized that there was a Cannabix to UFL grant for around ~18k. That is well known. It has been publicized that this company earns no income and that it needs to complete private placements on a need be basis. In this industry, this is a very good sign.
No comment has been made publicly boasting about being funded. If it has, please show us. I believe that this is NOT the case, based on my reading of the aforementioned reports which are published by Cannabix on the CSE website.
I would disagree with the "feel good spin" comment. In this industry, with this particular type of arrangement (private company and university professor/laboratory), these types of private placements are the reason that Yost even bothers with Cannabix. Yost, because he is a professor at a University, can't private place his resource group... its not a company and not on the stock market. Cannabix is, and that is why this agreement between the two is so beneficial to both.
This is a great sign. Insiders going to pick up more shares.
This money... to fund Beta and to fund a clinical trial. Both being expensive. Acquired the patent rights. If they didn't have a device, they wouldn't need money to keep working on it and wouldn't acquire rights. Boock stock options as well.
From my experience, this is a great sign. University lab and external companies developing a device, where it is not possible for IP reasons to broadcast every single science development... this is their way of saying, we have something big here and it's working. Despite the dilution.
Cannabix going out and suggesting that they won't be using Breathtec's money is also great. Avoiding conflict there. Yost group is going to be VERY well funded after this.
I will 100% be purchasing a boat load of these if possible. This warrants explanation though. If this stays private, that is an incredible sign, as friends and family of the Mahli's are going to get RICH.
IMO this is a great sign. I believe they have reached a new stage in development and have committed to it's development. Don't be put off by the fact it will dilute share price, realize that they have acquired the patent rights and management hasn't sold any of their shares. These combined points, suggest that things just got serious and that there Beta is clearly working, to the point they are moving ahead with it and will show the world at Pittcon.
---
Cannabix Technologies Announces Non-Brokered Private Placement
For immediate release. Vancouver, British Columbia,February 1, 2016:Cannabix Technologies Inc.(CSE: BLO, OTC PINK: BLOZF) (the “Company”) announces that it intends to raise up to $1,000,000 via a non-brokered financing at $0.15 cents per unit. Each Unit consists of one common share and one non-transferable common share purchase warrant exercisable at $0.25 cents per common share for a period of 24 months from the date of closing. All warrants are subject to an early acceleration provision which provides for the mandatory exercise or expiry of the Warrants in the event Cannabix’s shares close at $0.30 or higher for at least 10 consecutive trading days. In such event, the Warrants will accelerate and expire 30 days after the Company has given notice of the accelerated conversion to the Warrant holders. Finders' fees may be payable in connection with the private placement. Proceeds will be used for Company’s technology development and working capital.
About Cannabix Technologies Inc.
Cannabix Technologies Inc. is a leader in marijuana breathalyzer development for law enforcement and the workplace. Cannabix has established breath testing technologies in the pursuit of bringing durable, portable hand-held tools to market to enhance detection of marijuana impaired driving offences on roads at a time when marijuana is becoming legal in many jurisdictions globally. Cannabix is working to develop drug-testing devices that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. This technology would be used to provide detection of use of THC at the roadside to identify drivers intoxicated by the recent use of marijuana. In particular, Cannabix is focused on developing breath testing devices for THC detection that would target recent use of THC, in contrast to saliva or urine testing for THC which can be invasive and take considerable time for laboratory analysis. The devices will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
We seek Safe Harbor.
On behalf of the Board of Directors
“Kal Malhi”
President
Cannabix Technologies Inc.
For further information, contact us at info@cannabixtechnologies.com
I am not sure there is a need to do this. They haven't done a news release for a reason. They have media package coming soon, for that, they will do a big news blitz.
I would suggest that anyone with the ability, should load up on these cheap shares while they can. I would say we will be into the dollars range come March post-Pittcon with Beta.
But that is a good point, a news blitz is likely coming Shell3. Management told me they have a media package coming, and the corporate presentation is part of that.
Tied up with work right now. Will post in a few hours.
For the time being, just remember: we have just been given a public declaration that these guys have some sort of device that they have been testing for the past few months and it is working. They would not have exercised the rights if it wasn't. They are funded very well to take this next level. Mahli announced they will have the device on the road in 18 months (could be longer), but this suggests we can expect beta in the next 6 months (allowing 1-2 years of trial testing + court approval, which is normal).
IMPORTANT: The corporate presentation has yet to be posted, that will be very positive. We are still going to get media, and more positive PR and eventually beta.
Highly likely Beta will be released to the world at Pittcon. Timing will work well. Time for them to redeem themselves. Shell3, you are right, Beekman and MANY OTHER CONTACTS of Yost, could be VERY beneficial in getting through the legal process. But don't forget, that while Beekman could be important, THE GOVERNMENT wants this device. Legal will be expedited by the government.
I wouldn't be surprised if government funded the trials and helped get them going, once Beta is released. Yost has done this before, the government will take him seriously.
This news release is directly in agreement with what I heard when I spoke with management.
Finally, let's make some money.
This is fantastic news. Glad to see they are committed and are making a public statement that suggests they are full steam ahead. Time to pick up some more shares at this price, because when beta is released (soon), you can guarantee we won't see levels like this ever again.
The Yost group has 3 million in funding now. Call it Breathtec, call it Cannabix, who cares. At the end of the day, I personally feel Breathtec was a saving grace. The miniaturization of FAIMS is now getting handled by two brilliant scientists under the supervision of a world leader in the field.
Game on. Bubba Mahli called it, watch Cannabix rise with Breathtec.
I do believe that actually. I have strong reason to believe so.
1) I have worked in the medical tech. industry, done graduate school and medical school working both in analytic techniques such as mass spectrometry, drug development, and drug recognition. Most importantly, I understand the science of FAIMS.
2) 1 supervisor. Yost. Two students, Costanzo and Boock. Same technology used by each. Same machine used by each (FAIMS in the Lab). Different ghraduate student PhD projects simply because the same technology was used to idfentify different compounds.
3) Different compounds you look for (THC vs. biomarkers), doesn't matter. It's the same technology used for each (FAIMS). It presented an opportunity for two companies.
4) A small handheld you blow into, is a small handheld you blow into. Why can't it be used in both settings... it's not likely the device used to detect THC is going to have a big weed symbol printed on it.
5) You have seen the Alpha prototype renderings? You have seen the recent Breathtec device rendering? They look pretty similar to me.
How are you justifying your opinion?
The Breathtec video teaser, includes a image of a device that they claim is a "rendering of device under development".
You will remember that Cannabix had similar drawings rendered of the Alpha prototype.
It is common for companies to release the most up-to-date renderings possible; images that look as close to possible as could be predicted.
These guys have been working on Alpha and FAIMS for so long, that it is possible that this device is what the hand-held will look like.
Remember that, it is the same handheld for both Breathtec and Cannabix, just slightly different in terms of recognition.
Therefore, it is likely that Cannabix will have a device rendering (another set of media images and possibly video) that will appear similar to the rendering presented in the Breathtec video clip.
I say it does not exist yet, because technically, Cannabix must publish the images before stock holders can know for sure, that the device will look similar. I believe it will, because it's the same technology. They might make it look slightly different because, they want the two companies to remain separate without having criticism that they are doing the same thing twice, jeopardizing funding/legal.
Management has suggested to several people that the new corporate presentation and media package for Cannabix, which outlines a new proposed timeline, and provides device renderings that will replace the outdated Alpha images, is coming in the new year. It should be coming soon, as many would acknowledge, but I cannot guarantee this week, that is a guess (though likely).
I have taken a quote from his article. It is clear to me, that the author of the article fails to understand that the technology is the same (FAIMS) for both companies.
If Breathtec is a watch, then Cannabix should be too.
Indeed, if Breathtec runs, it is the same technology, Cannabix should to. If Breathtec has tons of funding for their device... it is the same device for Cannabix, so Cannabix is well funded too. There is a reason that these companies are so closely linked. Win-Win.
Maybe Bubba Mahli was right SHell3. Let's watch Cannabix run with Breathtec. Maybe management is smarter than we think. They used Breathtec as a new company to generate money to develop the existing technology.
To stimulate discussion:
- Giving Boock stock options... did he reach a milestone?
- What kind of media can we expect in the upcoming news release?
- What will be revealed in the upcoming corporate presentation, perhaps a call for funding? An announcement that the exclusive rights are going to be acquired for FAIMS?
- Annual General Meeting this spring... too attend?
- Conference in Atlanta... too attend?
- Breathtec being well financed... benefiting the development of a FAIMS handheld, which directly translates to Costanzo and Boock "working together" to build a device they can both use, benefiting both companies?
- A new patent in the works?
Breathtec has released a video in which it promotes it's IPO. The video contains a "rendering" of the device being put together currently. It is not a "beta" device however. Cannabix has yet to release any Beta renderings, but we expect to see them this week.
I think the most important date is still going to be July. If these guys acquire the rights, that says everything. If they don't, then we get the idea.
If Cannabix builds there handheld that successfully utilizes the full capacity of FAIMS, then Breathtec will be able to do the same. It is the same technology.. The difference is that they run a different method and look for a different ion.
Despite posts from those who express concern about Breathtec stealing the show, these companies and their individual success, is mutually beneficial. Because, no matter who builds a handheld-FAIMS first, both companies win. THC, liver enzymes, biomarkers for Alzherimer's, it is all the same, you just have to look to different spots on the report/analytic reading. The same patent is being utilized by Cannabix and Breathtec for the scientific portion. This is wonderful. If Cannabix fails, so does Breathtec... because if they can't miniaturize FAIMS, then they can't, it doesn't matter for which company, because they blow into the same device....!
Management has generated a ton of new shares for themselves with Breathtec, utilizing the same technology, yes... but they still hold all of their shares in Cannabix. They have essentially doubled down. That is a great sign.
The Breathtec stock might ride some hype for a few months, but ultimately it will end up in the exact same place as Cannabix. They both are relying on the same technology and will use the same device. I agree. Should be a good thing. I see Cannabix RISING with Breathtec.
See my post I just made. The Breathtec deal doesn't stink at all!
I think that it is important to consider that, they have a detection system that can detect THC in breath with 100 percent accuracy, however, this device currently is the size of a large computer (or perhaps slightly bigger). This is not what police want (no BatMobile on their mind, though that sounds awesome). Police forces want something for easy road-side use, and a hand-held is on the top of the list.
I think Cannabix could have been selling huge devices by now, but they have spent their time by trying to build the handheld. This is in part due to the fact that (a) the police want the handheld, like I just mentioned (b) their ARE competitors who are legitimate, and likely many more of them that have yet to publicize their work (i.e. many European agencies working on this also, out of the spotlight).
To summarize. We have working technology, and we have the BEST working technology. I know that is scientifically true. At least for now. We need miniaturization, with retention of the accuracy. At tough feat, which we are AMAZINGLY close to achieving.
Fact of the matter is... these guys would have turned back by now if they lost faith. They are full steam ahead. Kal JUST said he is expecting a product in 18-24 months to be ON THE ROAD. That means we should expect beta in the next year. That means they will likely acquire the patent rights in July. If that happens, we are all going to be very rich.
To answer ILuBlo's question: They will acquire the patent rights to the Yost technology... that is only for FAIMS, that is not for a beta device which incorporates the concepts from the Alpha protoype and the FAIMS. We basically would be combining the already existing Alpha prototype patent, and the FAIMS patent, in a new patent. At which point shares are released. That will be the new "Beta". We are hoping that is closer than we think. And my conversation with management suggested that, with an accuracy level in the 90's, that is the case.
Not trying to be negative, but I think that the interview gives us a good picture of where these guys are at. They have not yet developed the device to a point of 100% accuracy, it is a work in progress. So, what does that mean with respect to technological development?
This isn't the type of device where you say, "AH, today we have reached another 2% accuracy". The mass spectrometer works with 100 % accuracy on the bench top, when the mass spectrometer is full size. The issue here, which was elaborated to me by management, is miniaturization. Unsurprising, it is a formidable challenge. Hopefully the next press release states the current accuracy measurement precisely, along with what steps have been taken to increase it, and how why investors should remain confident that it is possible.
I think this is expected, especially if Kal does a press release on a radio show suggesting that 18 months is a potential timeline. It would be poor management to make claims of that sort and not provide shareholders with scientific based reasoning/support.
This is going to get interesting. Again, to remind those on the board who have not been here in a while, that they have until the early summer to get Beta complete. They are incentivized by Form 2A, and they only have the rights to acquire the patent until July.
Ultimately we want to see Beta and the patent rights acquired by July. The full patent will see the release of the remaining shares to management.
Thoughts?
That would make him a hypocrite. I got a call, and shared my information on this board and was given heat by people like Gold and IluBlo for "pumping". You try to be helpful and get called out. Why bother then...
What? You will remember that 1.5 months ago I specifically stated that we will be receiving media and images with respect to FAIMS. Just wait, look forward to citing my previous posts. This Breathtec clip is a teaser. We will be getting something even better with the upcoming news release.
Ah, looking back at my post it looks like I was suggesting I have new information. I do not. I meant that I am excited to hear what has taken place!
Let's ride this to the moon! Big things coming! I am very excited to have some information about the scientific advancement that has been made. Let us hope these guys expose a little bit of the cutting edge technological advancement they have been carrying out behind the curtains.
When I spoke to management ONE month ago, they had a device that they claimed to be over 80 percent accurate.
So it is possible.
What I am not happy with, is that they have watched share holder value drop and done nothing at all about it. It is insane. It's steadily fallen from 50 cents without a peep. I do strongly believe that in this industry you do not put out scientific updates, I get that whole I.P. thing and am very familiar with it. However, you are a publicly traded company and should maintain share value if possible.
I hope they have something big in terms of news, or I am out.
You bring up some good points. I do recall the Bubba Mahli post and I think that we can all take it at face value... family is suggesting big things. However, I think there is more value in reading a bit deeper.
He says, "watch Cannabix blow up with Breathtec". My interpretation is the following (and I have never mentioned this before), I think that management has waited to release the Cannabix media and images and news, until Breathtec IPO was ready to go. Release both around the same time and get double the hype. My belief is that Cannabix will come first, it will demonstrate these guys are making progress and getting things done. Then Breathtec IPO goes public and everyone has faith, and invests.